Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
US7432245B2 · kind B2 · utility
0Cited by
7References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 2003 |
| Grant date | Oct 7, 2008 |
| Priority date | — |
| Expiry date | Nov 20, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Parenteral formulations of peptides which are useful for sustained release are disclosed. Also disclosed are methods of preparation for the formulations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.